The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial
Open accessAbstract
Background: Platelet Rich Plasma (PRP), a blood-derived product rich in growth factors, is a promising treatment for cartilage defects but there is still a lack of clinical evidence. The aim of this study is to show, through a randomized double blind prospective trial, the efficacy of this procedure, by comparing PRP to Hyaluronic Acid (HA) injections for the treatment of knee chondropathy or osteoarthritis (OA). Methods: 109 patients (55 treated with HA and 54 with PRP) were treated and evaluated at 12 months of follow-up. The patients were enrolled according to the following inclusion criteria: age> 18 years, history of chronic (at least 4 months) pain or swelling of the knee and imaging findings of degenerative changes of the joint (Kellgren-Lawrence Score up to 3). A cycle of 3 weekly injections was administered blindly. All patients were prospectively evaluated before and at 2, 6, and 12 months after the treatment by: IKDC, EQ-VAS, TEGNER, and KOOS scores. Range of motion and knee circumference changes were measured over time. Adverse events and patient satisfaction were also recorded. Results: Only minor adverse events were detected in some patients, such as mild pain and effusion after the injections, in particular in the PRP group, where a significantly higher post-injective pain reaction was observed (p=0.039). At the follow-up evaluations, both groups presented a clinical improvement but the comparison between the two groups showed a not statistically significant difference in all scores evaluated. A trend favorable for the PRP group was only found in patients with low grade articular degeneration (Kellgren-Lawrence score up to 2). Conclusions: Results suggest that PRP injections offer a significant clinical improvement up to one year of follow-up. However, conversely to what was shown by the current literature, for middle-aged patients with moderate signs of OA, PRP results were not better than those obtained with HA injections, and thus it should not be considered as first line treatment. More promising results are shown for its use in low grade degeneration, but they still have to be confirmed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Platelet-rich plasma: evidence to support its use
Marx, R. E. (2004) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2003.12.003 · Cited by 1,942
Platelet-Rich Plasma (PRP): What Is PRP and What Is Not PRP?
Marx, R. E. (2001) · Implant Dentistry · doi:10.1097/00008505-200110000-00002 · Cited by 1,704
Autologous platelets as a source of proteins for healing and tissue regeneration
Anitua, E., Andia, I., Ardanza, B., Nurden, P., & Nurden, A. (2004) · Thrombosis and Haemostasis · doi:10.1160/th03-07-0440 · Cited by 1,495
Cartilage injuries: A review of 31,516 knee arthroscopies
Curl, W. W., Krome, J., Gordon, E. S., Rushing, J., Smith, B. P., & Poehling, G. G. (1997) · Arthroscopy: The Journal of Arthroscopic & Related Surgery · doi:10.1016/s0749-8063(97)90124-9 · Cited by 1,402
Platelet-Rich Plasma: From Basic Science to Clinical Applications
Foster, T. E., Puskas, B. L., Mandelbaum, B. R., Gerhardt, M. B., & Rodeo, S. A. (2009) · The American Journal of Sports Medicine · doi:10.1177/0363546509349921 · Cited by 1,323
Articular cartilage defects: Study of 25,124 knee arthroscopies
Widuchowski, W., Widuchowski, J., & Trzaska, T. (2007) · The Knee · doi:10.1016/j.knee.2007.02.001 · Cited by 755
Comparison of Surgically Repaired Achilles Tendon Tears Using Platelet-Rich Fibrin Matrices
Sánchez, M., Anitua, E., Azofra, J., Andía, I., Padilla, S., & Mujika, I. (2007) · The American Journal of Sports Medicine · doi:10.1177/0363546506294078 · Cited by 653
Kon, E., Mandelbaum, B., Buda, R., Filardo, G., Delcogliano, M., Timoncini, A., Fornasari, P. M., Giannini, S., & Marcacci, M. (2011) · Arthroscopy: The Journal of Arthroscopic & Related Surgery · doi:10.1016/j.arthro.2011.05.011 · Cited by 582
Self-citationKon, E., Buda, R., Filardo, G., Di Martino, A., Timoncini, A., Cenacchi, A., Fornasari, P. M., Giannini, S., & Marcacci, M. (2010) · Knee Surgery, Sports Traumatology, Arthroscopy · doi:10.1007/s00167-009-0940-8 · Cited by 570
Self-citationIs platelet-rich plasma the perfect enhancement factor? A current review.
(2003) · The Journal of Prosthetic Dentistry · doi:10.1016/s0022-3913(03)00338-x · Cited by 566
Cited by
Repair and tissue engineering techniques for articular cartilage
Makris, E. A., Gomoll, A. H., Malizos, K. N., Hu, J. C., & Athanasiou, K. A. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.157 · Cited by 1,245
Chahla, J., Cinque, M. E., Piuzzi, N. S., Mannava, S., Geeslin, A. G., Murray, I. R., Dornan, G. J., Muschler, G. F., & LaPrade, R. F. (2017) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.16.01374 · Cited by 504
Meheux, C. J., McCulloch, P. C., Lintner, D. M., Varner, K. E., & Harris, J. D. (2016) · Arthroscopy: The Journal of Arthroscopic & Related Surgery · doi:10.1016/j.arthro.2015.08.005 · Cited by 445
Dai, W.-L., Zhou, A.-G., Zhang, H., & Zhang, J. (2017) · Arthroscopy: The Journal of Arthroscopic & Related Surgery · doi:10.1016/j.arthro.2016.09.024 · Cited by 444
Ayhan, E. (2014) · World Journal of Orthopedics · doi:10.5312/wjo.v5.i3.351 · Cited by 441
Metadata
- Authors
- Filardo, G., Kon, E., Di Martino, A., Di Matteo, B., Merli, M. L., Cenacchi, A., Fornasari, P. M., & Marcacci, M.
- Venue
- BMC Musculoskeletal Disorders
- Published
- 2012-11-23
- Volume
- 13
- Issue
- 1
- Pages
- 229-229
- ISSN
- 1471-2474 (ISSN-L)
- OpenAlex
- W2009242989
- Cited by
- 387
- References
- 28
- FWCI
- 37.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial. https://app.cochat.ai/papers/10.1186/1471-2474-13-229
- The paper
- Filardo, G., Kon, E., Di Martino, A., Di Matteo, B., Merli, M. L., Cenacchi, A., Fornasari, P. M., & Marcacci, M. (2012). Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial. BMC Musculoskeletal Disorders. https://doi.org/10.1186/1471-2474-13-229
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.